Table 16.
Ranking obtained under sensitivity analysis.
| Treatment | Rank (i) | Rank (ii) | Rank (iii) |
|---|---|---|---|
| Plasma Exchange | 3 | 2 | 2 |
| Tocilizumab | 4 | 3 | 3 |
| Remdesivir | 5 | 4 | 4 |
| Favipravir | 1 | 1 | 1 |
| Hydroxychloroquine | 2 | 1 | 2 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.